SignalPoint Asset Management’s GSK GSK Stock Holding History

SignalPoint Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,566	Closed	-$268K	–	173
2016 Q4	$268K	Buy	5,566 +124	+2%	+$6.13K	0.07%	215
2016 Q3	$293K	Buy	5,442 +180	+3%	+$9.87K	0.08%	189
2016 Q2	$285K	Buy	5,262 +820	+18%	+$43.2K	0.12%	184
2016 Q1	$225K	Sell	4,442 -3	-0.1%	-$149	0.1%	203
2015 Q4	$224K	Sell	4,445 -153	-3%	-$7.8K	0.1%	174
2015 Q3	$221K	Sell	4,598 -68	-1%	-$3.54K	0.1%	166
2015 Q2	$269K	Hold	4,666	–	–	0.11%	152
2015 Q1	$269K	Buy	4,666 +4	+0.1%	+$229	0.11%	152
2014 Q4	$249K	Buy	4,662 +544	+13%	+$30.4K	0.11%	134
2014 Q3	$237K	Buy	4,118 +640	+18%	+$39.2K	0.11%	138
2014 Q2	$233K	Buy	3,478 +84	+2%	+$5.69K	0.1%	149
2014 Q1	$227K	Buy	3,394 +322	+10%	+$21.8K	0.11%	143
2013 Q4	$205K	Buy	+3,072	New	+$199K	0.09%	148

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SignalPoint Asset Management's GSK Position: Q1 2017 in Review

SignalPoint Asset Management sold out of GSK (GSK) in Q1 2017, closing a stake of 5,566 shares — an estimated $268K sold.

SignalPoint Asset Management first reported a position in GSK in Q4 2013 and held it in 13 quarters. The position peaked at $293K in Q3 2016. 786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

SignalPoint Asset Management reported no remaining GSK position as of Q1 2017 after selling out during the quarter.
SignalPoint Asset Management sold 5,566 GSK shares in Q1 2017, an estimated $268K.
SignalPoint Asset Management first reported a position in GSK in Q4 2013 and held it in 13 quarters.
SignalPoint Asset Management's GSK position peaked at $293K in Q3 2016.
786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on SignalPoint Asset Management's 13F filing for Q1 2017, filed 2 May 2017.